Your vote could mean $10,000 or more for SENS Foundation to put toward our groundbreaking research into effectively mitigating age-related disease. To vote, simply visit SENS Foundation's official Chase Community Giving page.
This month, a paper reporting results from the LysoSENS project that SENS Foundation funds at Rice University will be published in the printed edition of Biotechnology and Bioengineering. The research that produced these results was primarily performed by Dr. Jacques Mathieu, and focused on identifying enzymes that can degrade or modify 7-ketocholesterol, a root cause of atherosclerosis; such enzymes could ultimately be used as a new class of regenerative therapies to prevent and reverse heart disease.
In this series of four interviews, suitable for viewers with or without a scientific background, Dr de Grey explains the key ideas, initial results and projected outcomes of the SENS program, and explains how SENS Research Foundation operates to educate and inform the public about the conceptual and practical advantages of rejuvenation biotechnology.
The "Debate of the Ages", hosted by the Oxford University Scientific Society and featuring SENS Foundation's Chief Science Officer Dr Aubrey de Grey and Oxford's Professor Colin Blakemore, has been recorded courtesy of SENS Foundation and is now available via our YouTube channel.
"This house wants to defeat ageing entirely"; Dr de Grey to debate Professor Colin Blakemore in Oxford, April 25thPosted by Daniel Kimbel on April 17, 2012 | Outreach
Oxford University Scientific Society is hosting a debate on Wednesday, 25th April, 2012. Dr. Aubrey de Grey will propose the motion "This house wants to defeat ageing entirely" and Professor Colin Blakemore will be opposing. The debate will be chaired and moderated by Professor Sir Richard Peto. This debate will address whether it is feasible and appropriate to consider ageing as a target of decisive medical intervention, raising the possibility of substantial extension of human lifespan.
I'm pleased to bring you a detailed summary of our expanding intra- and extramural programs in our Research Report for 2011, along with upcoming milestones and goals for the year ahead.
It's with great pleasure that I announce the release of our Annual Report for 2011. The report includes updates on all of our research projects, both at the Research Center in Mountain View, and at leading universities and institutions around the world. It reviews the success of SENS 5 and the expansion of our Academic Initiative, and summarises our financial situation through 2011.
An archived copy of SENS Research Foundation's 2011 Holiday Appeal newsletter.
On 19 September, 2011, Sarah Marr will be stepping down as our Executive Vice President at SENS Foundation. She has been a committed co-founder, and she will of course continue to be a trusted advisor and closely involved with the organization. But we couldn't have her term of full-time service with us pass without noting the significant contribution she has made to the professionalism of the organization and to the quality of our overall message.
SENS Foundation's Year End Report for 2010, including an overview of the year from our CEO, Mike Kope; a research summary from CSO Aubrey de Grey; commentaries on our Research Center operations and our outreach activities; and a breakdown of our 2010 finances.
SENS Foundation is pleased to announce that it has been granted tax-exempt status as a 501(c)(3) public charity, with an effective date of March 9, 2009. Donations to the Foundation are fully deductible as a charitable contribution.
The global scientific community is increasingly recognizing the role of rejuvenation biotechnologies in addressing age-related disease. This week, Arizona-based businessman Jason Hope announced a $500,000 donation to SENS Foundation, a California-based non-profit organization that works to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease.